Is a complete KLSE/DPHARMA research report available?

No complete published report is available for klse/DPHARMA (KLSE/DPHARMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

klse/DPHARMA stock profile: metrics, valuation and analysis

Market cap	1.2B
Revenue (ttm)	929.4M
Net income (ttm)	102.2M
EPS (ttm)	MYR 0.11
Shares out	961.9M
P/E (trailing)	11.8x
P/E (forward)	11.3x
Dividend	MYR 0.05 (3.57%)
Volume	395,400
Beta	0.35

All KLSE/DPHARMA indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

MYR

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Malaysia
Country code	MY
Employees	1,957
Employees Change	307%
Employees Change Percent	18.61
Enterprise value	MYR 1.4B
Exchange	Bursa Malaysia
Financial currency	MYR
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Industry PE	11.04
Industry PE Fwd	9.45
Last refreshed	2026-09-05
Market cap	MYR 1.2B
Price	MYR 1.25
Price currency	MYR
Rev Per Employee	474,914.67x
Sic	2834
Symbol	klse/DPHARMA
Website	https://duopharmabiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.5%
EV Earnings	13.9x
EV/EBIT	9.35x
EV/EBITDA	7.4x
EV/FCF	22.02x
EV/Sales	1.53x
FCF yield	5.37%
Forward P/E	11.34x
P/B ratio	1.53x
P/E ratio	11.77x
P/S ratio	1.29x
PE Ratio10 Y	20.44x
PE Ratio3 Y	18.37x
PE Ratio5 Y	19.29x
PEG ratio	0.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.35%
EBITDA Margin	20.28%
FCF margin	6.94%
Gross margin	41.27%
Gross Profit	MYR 383.6M
Gross Profit Growth	16.7%
Gross Profit Growth Q	19.76%
Gross Profit Growth3 Y	10.62%
Gross Profit Growth5 Y	9.91%
Net Income	MYR 102.2M
Net Income Growth	33.56%
Net Income Growth Q	47.84%
Net Income Growth Qo Q	-2.75%
Net Income Growth3 Y	14.17%
Net Income Growth5 Y	10.05%
Pretax Margin	14.45%
Profit Margin	11%
Profit Per Employee	MYR 52,225
ROA	6.61
Roa5y	4.84
ROCE	13.14
ROE	13.43
Roe5y	10.01
ROIC	11.71
Roic5y	8.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.66%
Cagr15y	10.14%
Cagr1y	-4.67%
Cagr20y	8.61%
Cagr3y	5%
Cagr5y	-6.44%
Div CAGR10	5.87%
Div CAGR3	25.53%
Div CAGR5	-1.37%
EPS Growth	33.38
EPS Growth Q	47.86
EPS Growth Qo Q	-2.66
EPS Growth3 Y	13.86
EPS Growth5 Y	9.58
FCF Growth	-35.01%
OCF Growth	-37.86%
OCF Growth Q	-95.75%
OCF Growth Qo Q	-96.95%
OCF Growth10 Y	3.99%
OCF Growth3 Y	33.15%
OCF Growth5 Y	7.54%
Revenue Growth	4.79x
Revenue Growth Q	5.67x
Revenue Growth Qo Q	-5.46x
Revenue Growth3 Y	10.07x
Revenue Growth5 Y	9.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	MYR 0.65
Assets	MYR 1.5B
Cash	MYR 256M
Current Assets	MYR 844.1M
Current Liabilities	MYR 301.3M
Debt	MYR 474.1M
Debt EBITDA	MYR 2.47
Debt Equity	MYR 0.6
Debt FCF	MYR 7.35
Equity	MYR 786.1M
Interest Coverage	6.58
Liabilities	MYR 671.6M
Long Term Assets	MYR 613.6M
Long Term Liabilities	MYR 370.2M
Net Cash	MYR -218.1M
Net Cash By Market Cap	MYR -18.14
Net Debt EBITDA	MYR 1.16
Net Debt Equity	MYR 0.28
Net Debt FCF	MYR 3.38
Tangible Book Value	MYR 751.2M
Tangible Book Value Per Share	MYR 0.78
WACC	5.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.8
Inventory Turnover	1.94
Net Working Capital	MYR 421.7M
Quick ratio	1.79
Working Capital	MYR 542.7M
Working Capital Turnover	MYR 1.66

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.14%
Dividend Growth	30%
Dividend Growth Years	2%
Dividend per share	MYR 0.05
Dividend Years	24
Dividend Yield	3.57%
Ex Div Date	2026-09-03
Last Dividend	MYR 0.02
Payout Frequency	Semi-Annual
Payout Ratio	42.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	151.53%
1Y total return	-4.66%
200-day SMA	1.29
3Y total return	15.78%
50-day SMA	1.24
50-day SMA vs 200-day SMA	50under200
5Y total return	-28.29%
All Time High	3.29
All Time High Change	-61.95%
All Time High Date	2020-11-10
All Time Low	0.32
All Time Low Change	288.92%
All Time Low Date	2002-07-26
ATR	0.03
Beta	0.35
Beta1y	0.23
Beta2y	0.41
High	1.3
High52	1.57
High52 Date	2026-02-19
High52ch	-20.38%
Low	1.24
Low52	1.18
Low52 Date	2026-07-02
Low52ch	5.93%
Ma50ch	1.21%
Price vs 200-day SMA	-3.1%
RSI	48.75
RSI Monthly	47.62
RSI Weekly	47.73
Sharpe ratio	-0.05x
Sharpe Ratio3y	0.04x
Sharpe Ratio5y	-0.3x
Sortino ratio	0.14
Sortino Ratio3y	0.29
Sortino Ratio5y	-0.23
Total Return	3.43%
Tr YTD	3.34
Tr15y	325.92%
Tr1m	4.52%
Tr1w	-1.19%
Tr3m	3.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	529,680,949%
Net Borrowing	-21,549,000
Shares Insiders	0.3%
Shares Institutions	66.69%
Shares Out	961,942,451
Shares Qo Q	0%
Shares Yo Y	0.14%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	446,545x
Bv Per Share	0.82
CAPEX	MYR -18.3M
Ch10y	89.71
Ch15y	78.39
Ch1m	3.31
Ch1w	-2.34
Ch1y	-8.76
Ch20y	38.4
Ch3m	2.46
Ch3y	5.93
Ch5y	-36.16
Ch6m	-15.54
Change	-3.85%
Change From Open	-3.1
Close	1.3
Days Gap	-0.77
Depreciation Amortization	36,535,000
Dollar Volume	494,250
Earnings Date	2026-11-06
EBIT	MYR 152M
EBITDA	MYR 188.5M
EPS	MYR 0.11
F Score	6
FCF	MYR 64.5M
FCF EV Yield	4.54x
FCF Per Share	MYR 0.07
Financing CF	-65,318,000
Fiscal Year End	December
Founded	1,978
Graham Number	1.39743
Graham Upside	11.79
Income Tax	MYR 32.1M
Investing CF	-17,997,000
Is Primary Listing	1
Last Earnings Date	2026-02-19
Last Report Date	2026-06-30
Last Split Date	2021-09-06
Last Split Type	Forward
Lynch Fair Value	MYR 1.07
Lynch Upside	-14.63
Ma150	1.3
Ma150ch	-3.62%
Ma20	1.25
Ma20ch	-0.32%
Net CF	487,000
Next Earnings Date	2026-11-06
Open	1.29
P FCF Ratio	18.64
P OCF Ratio	14.51
Payment Date	2026-09-21
Position In Range	16.67
Ppne	545,629,000
Price EBITDA	MYR 6.38
Ptbv Ratio	1.6
Relative Volume	0.89x
Revenue	929,408,000x
Tax By Revenue	3.45x
Tax Rate	23.9%
Tr20y	422%
Tr6m	-12.72%
Volume	395,400
Z Score	2.98

KLSE/DPHARMA (KLSE/DPHARMA)

Price

Financial snapshot

Fair-value bridge

Latest news · KLSE/DPHARMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KLSE/DPHARMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on KLSE/DPHARMA

Frequently asked questions